Hypertension
Conditions
Interventions
Gold Standard:Systolic and diastolic blood pressure were recorded by an electronic blood pressure monitor in the ward.
Index test:Systolic blood pressure and diastolic blood pressure were measured with the experimental watch.
Sponsors
Fuwai Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 65 years, inclusive. 2. Good compliance, able to independently cooperate to complete the study procedures. 3. Voluntarily participated and provided signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Inter-arm blood pressure difference >= 10 mmHg. 2. Inability to maintain a stable posture (e.g., due to Parkinson's disease, sequelae of cerebrovascular disease, etc.). 3. Significant cardiac arrhythmia, including persistent atrial fibrillation, frequent premature beats (>=6 per minute), significant bradycardia (=100 bpm). 4. Postoperative status of pacemaker implantation. 5. Cardiac diseases (including coronary heart disease, heart failure, valvular heart disease, cardiomyopathy, myocarditis, congenital heart disease) that are in an acute phase or of severe degree, leading to hemodynamic instability. 6. Severe organic diseases, such as severe hepatic or renal insufficiency, respiratory failure, or malignant tumors. 7. Peripheral vascular disease or impaired circulation: e.g., severe anemia, infection and shock states, Raynaud's disease, severe arteriosclerosis. 8. Skin conditions that may affect the accuracy of wearable device measurements, including localized lesions at the wearing site (e.g., severe burns, scars, trauma, subcutaneous nodules) and/or systemic skin diseases (e.g., extensive eczema, scars, dermatitis herpetiformis, psoriasis). 9. Presence of a tattoo on the skin at the measurement (wearing) site. 10. History of psychiatric disorders or presence of cognitive dysfunction. 11. Participation in any other clinical trial that may interfere with this study within the past 30 days. 12. Any other condition deemed by the investigator as unsuitable for participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean error and standard deviation of systolic blood pressure;Mean error and standard deviation of diastolic blood pressure; | — |
Countries
China
Contacts
Public ContactMa Wenjun
Fuwai Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed